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Two Serious Cases of Infection with Clostridium celatum after 40
Years in Hiding?
Charlotte Nielsen Agergaard, Silje Vermedal Hoegh, Hanne Marie Holt, Ulrik Stenz Justesen
Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark
Clostridium celatum [ce.la’tum. L. adj. celatum hidden] has been known since 1974, when it was isolated from human feces. In
40 years, no association with human infection has been reported. In this work, we present two serious cases of infection with the
anaerobic Gram-positive rod Clostridium celatum.
CASE REPORTS
Case 1. A 53-year-old man presented at the emergency depart-ment 4 days after open surgery with removal of the gallblad-
der. The patient had been experiencing increasing pain in the up-
per abdomen and the right shoulder. He had no prior medical
history and was taking no medication.
On physical examination, the patient’s temperature was
37.8°C, heart rate was 86 bpm, blood pressure was 167/100 mm
Hg, and oxygen saturation level was 100% without supplemental
oxygen. An abdominal computed tomography (CT) scan revealed
intra-abdominal fluid. Six hours later, the patient became septic,
with a temperature of 38.4°C, a respiratory frequency of 28 breaths
per min, a heart rate of 102 bpm, and an oxygen saturation level of
90%. His abdominal pain increased despite treatment with mor-
phine. The leukocyte count was 22  109/liter (normal value
range, 3.5  109/liter to 8.8  109/liter), and the C-reactive pro-
tein (CRP) level was 142 mg/liter (normal value range,6.0 mg/
liter). Two sets of blood cultures (BacT/Alert using standard aer-
obic and anaerobic culture bottles; bioMérieux, Marcy l’Etoile,
France), 40 ml in total, were drawn, and treatment was initiated
with intravenous cefuroxime (1.5 g) and metronidazole (500 mg)
administered three times daily. The next morning, intraperitoneal
drainage was instituted by ultrasonic guidance and 300 ml of
bloody bile was removed. Subsequent endoscopic retrograde
cholangiopancreatography revealed a leak in an aberrant bile
duct, and two stents were inserted in the ductus choledochus.
On hospital day 11, a rise in temperature, a CRP elevation from
143 to 211 mg/liter, and an increase in leukocyte count from 18
109/liter to 39 109/liter prompted a CT scan of the abdomen and
a change of antibiotic treatment from cefuroxime to intravenous
meropenem (1 g) three times daily. The CT scan revealed progres-
sion of the intra-abdominal fluid, and 300 ml of purulent bile was
evacuated by catheter insertion. The discharge slowly decreased,
and the intra-abdominal catheter was finally removed on hospital
day 25. The following day, antibiotic treatment was stopped and
the patient, having received a total of 24 days of treatment with
intravenous antibiotics metronidazole (days 1 to 24), cefuroxime
(days 1 to 10), and meropenem (days 10 to 24), was discharged.
Blood cultures showed growth of anaerobic Gram-variable
rods from both anaerobic bottles after 1 day of incubation.
Growth on chocolate agar supplemented with vitamin K and cys-
teine (Statens Serum Institut [SSI], Hillerød, Denmark) was ob-
served after another 24 h in an anaerobic atmosphere. No aerobic
growth was observed. The isolates were subjected to matrix-as-
sisted laser desorption ionization–time of flight mass spectrome-
try (MALDI-TOF MS) using two different platforms (Vitek MS
1.4.2.B [bioMérieux, Marcy l’Etoile, France] and Biotyper 3.1-65
[Bruker Daltonics, Bremen, Germany]) with or without formic
acid. The Biotyper platform suggested Clostridium sp. (score,
1.945) and C. disporicum (score, 1.778), and the Vitek MS plat-
form suggested C. clostridioforme (score, 99.9) for both isolates.
To further identify the isolates, partial 16S rRNA gene sequencing
(MicroSeq 500 system; Perkin-Elmer, Applied Biosystems Divi-
sion, Foster City, CA) was performed. Isolate consensus sequences
(462 bp) were compared using the EzTaxon server and showed
99.49% and 99.74% matches (blood isolates 1 and 2, respectively)
to C. celatum type strain DSM 1785(T) (GenBank accession no.
X77844) (1). There was good separation from the second-best
match, C. disporicum type strain DSM 5521(T) (97.84%) (Gen-
Bank accession no. Y18176).
Case 2. An 87-year-old woman with a history of osteoporosis,
knee arthrosis, and total right-side knee arthroplasty was admitted
to the orthopedic department with a painful, swollen, and warm
left knee. She had undergone a total knee arthroplasty of the left
knee 23 days prior to admission.
On admittance, her temperature was 38.3°C. The total leuko-
cyte count was 10.7  109/liter, and the CRP level was 115 mg/
liter. Antibiotic treatment with oral amoxicillin-clavulanic acid
(500 and 125 mg, respectively) and dicloxacillin (1 g) three times
daily was initiated. A culture of a sterile knee puncture on hospital
day 3 was without aerobic or anaerobic growth. Partial 16S rRNA
gene sequencing was performed on the sample but with no posi-
tive result. Amoxicillin-clavulanic acid and dicloxacillin were dis-
continued in favor of intravenous cefuroxime (1.5 g three times a
day). The patient still showed symptoms from the knee on hospi-
tal day 13, and open surgery was performed. Synovial fluid was
cloudy, and soft tissue including the synovial tissue appeared gray
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and infected. A total of eight biopsy specimens were taken. Five
were bone biopsy specimens, and three were from soft tissue. An-
tibiotic treatment was changed to intravenous meropenem (1 g
three times a day) and vancomycin (1 g twice a day). No aerobic or
anaerobic growth was observed after 5 days of incubation, and the
bone biopsy specimens were submitted for partial 16S rRNA gene
sequencing (MicroSeq 500 system). 16S rRNA gene analysis of the
five culture-negative bone biopsy specimens resulted in five se-
quences of 453 to 462 bp. These were compared using the EzTaxon
server, and all sequences had a 100% match to C. celatum type
strain DSM 1785(T) (GenBank accession no. X77844).
The three soft tissue samples, which had been suspended in a
thioglycolate broth, were recultured. On hospital day 24, 11 days
after synovectomy, the three recultured tissue biopsy specimens
revealed anaerobic growth on chocolate agar supplemented with
vitamin K and cysteine (SSI). Treatment with vancomycin was
changed to metronidazole (500 mg three times a day). The mero-
penem treatment was continued. The isolates (tissue isolates 1 to
3) were subjected to MALDI-TOF MS on the two different plat-
forms (Vitek MS and Biotyper) with or without formic acid. The
Biotyper suggested C. disporicum, with scores of 1.785, 2.018, and
1.808, respectively, and the Vitek MS suggested C. paraputrificum
(99.9), C. paraputrificum (99.5), and C. clostridioforme (98.9), re-
spectively. One of the isolates (tissue isolate 3) was subjected to
partial 16S rRNA gene sequencing. The consensus sequence (460
bp) had a 100% match to C. celatum type strain DSM 1785(T)
(GenBank accession no. X77844).
The patient was discharged after completing a 24-day course of
intravenous antibiotics: cefuroxime (admission days 4 to 13),
meropenem (admission days 13 to 26), vancomycin (admission
days 13 to 24), and metronidazole (admission days 24 to 28). She
made an uneventful recovery.
The antimicrobial susceptibility of blood isolate 1 and tissue
isolate 3 to seven different antimicrobial agents was determined
using the Etest gradient method (bioMérieux, Lyon, France) and
M.I.C.Evaluators (Oxoid, Hants, United Kingdom) on brucella
blood agar supplemented with hemin and vitamin K (Becton,
Dickinson GmbH, BD Diagnostics, Heidelberg, Germany) ac-
cording to the manufacturers’ instructions. The isolates were sus-
ceptible to penicillin, piperacillin-tazobactam, meropenem,
metronidazole, clindamycin, moxifloxacin, and vancomycin ac-
cording to CLSI breakpoints for anaerobic bacteria (Table 1).
There have been no reports on human infection with C. cela-
tum, and only one publication was retrieved on PubMed describ-
ing how C. celatum is unable to reduce the dye indigo for industrial
purposes (2, 3). Within a period of 1 week, we isolated C. celatum
from blood and synovial tissue from two different patients admit-
ted at two different hospitals.
Clostridium celatum is a Gram-positive, nonmotile, anaerobic
rod with large endospores that was first isolated from human feces
4 decades ago. The bacterium was found in 14 of 60 fecal speci-
mens from healthy adults, and the species was as numerous as C.
perfringens in normal stool (2).
Our isolates grew as large (2 to 4 mm in diameter), circular,
flat, opaque, and pale gray colonies with a small central crest and
irregular edges on chocolate agar under conditions of anaerobic
incubation. Wet-mount microscopy performed on two isolates
(blood isolate 1 and tissue isolate 3) showed nonmotile rods with
large spores. Hauschild and Holdeman found that C. celatum pro-
duced nitrite and sulfide, and, of note, 4 of 14 strains were tested
for production of urease and all tested positive (growth from egg
yolk agar incubated in peptone yeast-urea broth). Hauschild and
Holdeman also found that C. celatum ferments a number of car-
bohydrates, including mannose (2). We tested both isolates for
urease production with the API RapidID 32A test (bioMérieux,
Marcy l’Etoile, France) and a specific urease test (SSI Diagnostica,
Hillerød, Denmark) and found them negative in both urease tests
(Table 1). Both isolates tested negative for nitrite production and
negative for fermentation of mannose with the API RapidID 32A.
The isolates were also subjected to the API 20A test, and no fer-
mentation of carbohydrates, including mannose, was observed.
The Culture Collection of the University of Göteborg holds a C.
celatum isolate, CCUG 34252, which has also tested negative for
urease and nitrite production and negative for fermentation of
mannose. The CCUG 34252 isolate was found in intestinal mu-
cosa from an 89-year-old woman in 1995. It was previously iden-
tified as C. clostridioforme, but the identification was changed after
16S rRNA gene sequence analysis.
The genus Clostridium is large and heterogeneous and includes
more than 200 species. Accurate identification of these bacteria
has been difficult, and Clostridium spp. might very well have been
misidentified with phenotypic methods. In recent years, several
new species have been recognized and others reclassified using
newer molecular methods, such as 16S rRNA gene sequencing (4).
Among the medically significant Clostridium spp., C. perfrin-
gens is the dominating pathogen in cases of bacteremia. The major
portal of entry is the hepatobiliary and gastrointestinal tract. Re-
ports suggest that bacteremia with non-C. perfringens spp. affects
younger patients and is more frequently hospital acquired than C.
perfringens bacteremia (5). Septic arthritis due to Clostridium spp.,
on the other hand, is not a frequent occurrence. Among the re-




Blood isolate 1 Tissue isolate 3
MALDI-TOF MS
Vitek MS (% match) C. clostridioforme (99.9) C. clostridioforme (98.9)
Biotyper (score) C. disporicum (1.767) C. disporicum (1.808)
API RapidID 32A
(% match)
C. tertium (80.3) C. clostridioforme (99.3)
Numerical profile 4701004000 4161004000
Urease
API RapidID 32A Negative Negative
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ported cases, the knee is the location most often involved, and
several cases have occurred following invasive procedures per-
formed on the joint, as was the case with one of our patients (6).
Obviously, the finding of two cases of infection with C. celatum
after 40 years “in hiding” prompted further investigations to ex-
clude laboratory contamination or mixing of samples. We con-
cluded that the isolates were indeed not results of contamination
or mixing of samples; blood cultures and tissues originated from
patients admitted at two different hospitals, and the samples were
received 4 days apart and never handled in the same sections of the
laboratory. Furthermore, the blood and tissue isolates were sub-
mitted to several analyses in order to characterize and, if possible,
differentiate them. We found that the blood and tissue isolates
differed in levels of antimicrobial susceptibility and in biochemi-
cal reactions as well as in their 16S rRNA gene sequences (sequenc-
ing of samples from the two patients was performed on separate
days).
Antimicrobial susceptibility testing revealed that the blood iso-
late was more susceptible to penicillin and meropenem than the
tissue isolate (Table 1). The biochemical characteristics were de-
termined by the API Rapid ID 32A test. The blood isolate tested
positive for -galactosidase-6-phosphate and -glucosidase,
while the tissue isolate tested positive for -glucuronidase and
-arabinosidase. As C. celatum is not in the API database, the
system was unable to identify the isolates to the species level. The
closest matches were C. tertium, with an 80.3% score for blood
isolate 1, and C. clostridioforme, with a 99.3% score for tissue iso-
late 3. C. celatum is not part of the current MALDI-TOF MS da-
tabases for the Vitek MS platform or the Biotyper platform. Con-
sequently, the Biotyper platform suggested different species with
scores close to the cutoff for species identification (2.000). In
contrast, the Vitek MS platform suggested C. clostridioforme and
C. paraputrificum, with matches of 99.9% and 98.9%, respectively
(Table 1). Recently, Alby et al. reported numerous examples of
misidentifications with the Vitek MS system, including several
cases of misidentifications of anaerobic bacteria (7).
We routinely subject anaerobic bacteria from blood and other
sterile body sites to partial 16S rRNA gene sequencing if MALDI-
TOF MS is not able to identify an isolate with a score above the
cutoff value (8). Partial 16S rRNA gene sequencing identified but
also separated the two isolates, revealing differences of six nucle-
otides and two deletions between the isolates at the beginning of
the sequence (Fig. 1). However, this did not correspond well to the
excellent identification scores of the EzTaxon server, with 99.49%
and 100% matches for the blood and tissue isolates, respectively,
to C. celatum type strain DSM 1785(T) (GenBank accession no.
X77844) (1). After downloading the X77844 sequence, we discov-
ered that the initial region of our 16S sequences was not covered
by this sequence. Subsequently, we compared both of our se-
quences to the NCBI BLAST database and found a 99% match to
C. celatum type strain JCM 1394(T) (GenBank accession no.
AB971795) with 100% coverage. There was a total difference of
five bases for the blood isolates and of four bases plus two dele-
tions for the tissue isolates in comparison with the consensus se-
quence of C. celatum type strain JCM 1394(T).
To our knowledge, these are the first two documented cases of
Clostridium celatum as a potential human pathogen. In these two
cases, a MALDI-TOF MS platform and the API RapidID 32A sug-
gested identification of non-C. celatum species with convincing
scores. It is possible that C. celatum has been misidentified in the
clinical microbiology laboratory for the last 4 decades.
Access to patient records was granted by informed consent
from both patients.
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